Candida tropicalis in human disease

References

• Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). (2008). EUCAST definitive document EDef 7 1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts 1499. Clin Microbiol Infect 14, 398–405.
   PubMedGoogle Scholar
• Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. (1997). The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24, 1122–1128.
   PubMed Web of Science ®Google Scholar
• Alexander B D, Byrne T C, Smith K L, Hanson K E, Anstrom K J, Perfect. J R, Reller L B. (2007). Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 45, 698–706.
   PubMed Web of Science ®Google Scholar
• Almirante B, Rodriguez D, Park B J, Cuenca-Estrella M, Planes A M, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin S K, Morgan J, Rodriguez-Tudela. J L, Warnock D W, Pahissa A. (2005). Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance barcelona Spain from 2002 to 2003. J Clin Microbiol 43, 1829–1835.
   PubMed Web of Science ®Google Scholar
• Alvarez-Gasca M A, Arguero-Licea B, Pliego-Castaneda A, Garcia-Tena S. (1998). Fungal agents isolated from cancer patients. Rev Latinoam Microbiol 40, 15–24.
   PubMedGoogle Scholar
• Antoniadou A, Torres H A, Lewis R E, Thornby J, Bodey G P, Tarrand. J P, Han X Y, Rolston K V, Safdar A, Raad I I, Kontoyiannis D P. (2003). Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) 82, 309–321.
   PubMed Web of Science ®Google Scholar
• Arathoon E G, Gotuzzo E, Noriega L M, Berman R S, DiNubile M J, Sable C A. (2002). Randomized double-blind multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother 46, 451–457.
   PubMed Web of Science ®Google Scholar
• Arendrup M, Horn T, Frimodt-Moller N. (2002). In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 30, 286–291.
   PubMed Web of Science ®Google Scholar
• Arthington-Skaggs B A, Lee-Yang W, Ciblak M A, Frade. J P, Brandt M E, Hajjeh R A, Harrison L H, Sofair A N, Warnock D W. (2002). Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother, 46 2477–2481.
   PubMed Web of Science ®Google Scholar
• Asmundsdottir L R, Erlendsdottir H, Haraldsson G, Guo H, Xu J, Gottfredsson M. (2008). Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis 47, e17–e24.
   Google Scholar
• Barchiesi F, Calabrese D, Sanglard D, Falconi-Di-Francesco L, Caselli F, Giannini D, Giacometti A, Gavaudan S, Scalise G. (2000). Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44, 1578–1584.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Colombo A L, McGough D A, Fothergill A W, Rinaldi M G. (1994). In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 38, 1530–1533.
   PubMed Web of Science ®Google Scholar
• Bastide C, Carcenac A, Arrova F, Rossi D. (2005). Prostatic abscess due to Candida tropicalis. Prostate Cancer Prostatic Dis 8, 296–297.
   PubMedGoogle Scholar
• Benson P M, Roth R R, Hicks C B, 1987 Nodular subcutaneous abscesses caused by Candida tropicalis. J Am Acad Dermatol 16, 623–624.
   PubMedGoogle Scholar
• Bille J, Glauser M P. (1997). Evaluation of the susceptibility of pathogenic Candida species to fluconazole Fluconazole Global Susceptibility Study Group. Eur. J Clin Microbiol Infect Dis 16, 924–928.
   PubMed Web of Science ®Google Scholar
• Bistoni F, Vecchiarelli A, Cenci E, Sbaraglia G, Perito S, Cassone A, 1984 A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice. Sabouraudia 22, 409–418.
   PubMedGoogle Scholar
• Bizerra F C, Nakamura C V, de P C, Estivalet Svidzinski T I, Borsato Quesada R M, Goldenberg S, Krieger M A, Yamada-Ogatta S F. (2008). Characteristics of biofilm formation by Candida tropicalis and antifungal resistance FEMS. Yeast Res 8, 442–450.
   PubMed Web of Science ®Google Scholar
• Blandin G, Ozier-Kalogeropoulos O, Wincker P, Artiguenave F, Dujon B. (2000). Genomic exploration of the hemiascomycetous yeasts: 16 Candida tropicalis. FEBS Lett 487, 91–94.
   PubMedGoogle Scholar
• Borg-von-Zepelin M, Meyer I, Thomssen R, Wurzner R, Sanglard D, Telenti A, Monod M. (1999). HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 113, 747–751.
   PubMedGoogle Scholar
• Borman A M, Linton C J, Miles S J, Johnson E M. (2008). Molecular identification of pathogenic fungi. J Antimicrob Chemother 61, Suppl 1 i7–12.
   PubMed Web of Science ®Google Scholar
• Burnie J P, Odds F C, Lee W, Webster C, Williams. J D, 1985 Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br Med. J (Clin Res Ed ) 290, 746–748.
   PubMed Web of Science ®Google Scholar
• Casalinuovo I A, Di F P, Garaci E. (2004). Fluconazole resistance in Candida albicans: a review of mechanisms. Eur Rev Med Pharmacol Sci 8, 69–77.
   PubMedGoogle Scholar
• Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G. (2008). Nosocomial candidaemia in children: results of a 9-year study. Mycoses 51, 248–257.
   PubMed Web of Science ®Google Scholar
• Chai Y A, Wang Y, Khoo A L, Chan F Y, Chow C, Kumarasinghe G, Singh K, Tambyah P A. (2007). Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital. Med Mycol 45, 435–439.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Reddy T C, Singhi S. (1997). Does candiduria predict candidaemia? Indian J Med Res 106513-6-6.
   Google Scholar
• Chen C Y, Chen Y C, Tang. J L, Yao M, Huang S Y, Tsai W, Chen Y C, Shen M C, Wang C H, Tien H F. (2003). Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence treatment and prognosis. Ann Hematol 82, 93–97.
   PubMed Web of Science ®Google Scholar
• Cheng Y R, Lin L C, Young T G, Liu C E, Chen C H, Tsay R W. (2006). Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 39, 155–161.
   PubMedGoogle Scholar
• Chou H H, Lo H J, Chen K W, Liao M H, Li S Y. (2007). Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis 58, 427–433.
   PubMedGoogle Scholar
• Chowdhary A, Becker K, Fegeler W, Gugnani H C, Kapoor L, Randhawa V S, Mehta G. (2003). An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses 46, 287–292.
   PubMedGoogle Scholar
• Chryssanthou E. (2001). Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method. J Clin Microbiol 39, 4181–4183.
   PubMed Web of Science ®Google Scholar
• Chryssanthou E, Cuenca-Estrella M. (2002). Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J Clin Microbiol 40, 3841–3844.
   PubMed Web of Science ®Google Scholar
• Cole G T, Halawa A A, Anaissie E J. (1996). The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 22, Suppl 2S73-88 -88.
   PubMedGoogle Scholar
• Cooke V M, Miles R J, Price R G, Midgley G, Khamri W, Richardson A C. (2002). New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 68 3622–3627.
   PubMed Web of Science ®Google Scholar
• Costa C R, de Lemos. J A, Passos X S, de Araujo C R, Cohen A J, Souza L K, Silva M R. (2006). Species distribution and antifungal susceptibility profile of oral Candida isolates from HIV-infected patients in the antiretroviral therapy era. Mycopathologia 162, 45–50.
   PubMedGoogle Scholar
• Costa S F, Marinho I, Araujo E A, Manrique A E, Medeiros E A, Levin A S. (2000). Nosocomial fungaemia: a 2-year prospective study. J Hosp Infect 45, 69–72.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Lee-Yang W, Ciblak M A, Arthington-Skaggs B A, Mellado E, Warnock D W, Rodriguez-Tudela. J L. (2002). Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species. Antimicrob Agents Chemother 46, 3644–3647.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Moore C B, Barchiesi F, Bille J, Chryssanthou E, Denning D W, Donnelly. J P, Dromer F, Dupont B, Rex. J H, Richardson M D, Sancak B, Verweij P E, Rodriguez-Tudela. J L. (2003). Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect 9, 467–474.
   PubMed Web of Science ®Google Scholar
• d’Enfert C. (2009). Hidden killers: persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol 12, 358–364.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Paugam A, Develoux M, Chochillon C, Matheron J, Datry A, Bouges-Michel C, Bonnal C, Dromer F, Bretagne S. (2010). Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. Clin Microbiol Infect 16, 863–869.
   PubMedGoogle Scholar
• de la Torre P, Reboli A C. (2007). Anidulafungin: a new echinocandin for candidal infections. Expert Rev Anti Infect Ther 5, 45–52.
   PubMed Web of Science ®Google Scholar
• De-Bernardis F, Arancia S, Morelli L, Hube B, Sanglard D, Schafer W, Cassone A. (1999). Evidence that members of the secretory aspartyl proteinase gene family in particular SAP2 are virulence factors for Candida vaginitis. J Infect Dis 179, 201–208.
   PubMedGoogle Scholar
• de-Repentigny L, Phaneuf M, Mathieu L G. (1992). Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice. Infect Immun 60, 4907–4914.
   PubMedGoogle Scholar
• Denning D W, Kibbler C C, Barnes R A. (2003). British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 3, 230–240.
   PubMed Web of Science ®Google Scholar
• Doebbeling B N, Lehmann P F, Hollis R J, Wu L C, Widmer A F, Voss A, Pfaller M A. (1993). Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis 16, 377–383.
   PubMed Web of Science ®Google Scholar
• Doi M, Homma M, Chindamporn A, Tanaka K. (1992). Estimation of chromosome number and size by pulsed-field gel electrophoresis (PFGE). in medically important Candida species. J Gen Microbiol 138, 138–51.
   Google Scholar
• Dorko E, Jenca A, Pilipcinec E, Danko J, Svicky E, Tkacikova L. (2001). Candida-associated denture stomatitis. Folia Microbiol (Praha) 46, 443–446.
   PubMedGoogle Scholar
• Dorko E, Kmet’ova M, Marossy A, Dorko F, Molokacova M. (1999). Non-albicans Candida species isolated from plastic devices. Mycopathologia 148, 117–122.
   PubMedGoogle Scholar
• Dorko E, Viragova S, Pilipcinec E, Tkacikova L. (2003). Candida–agent of the diaper dermatitis? Folia Microbiol (Praha) 48, 385–388.
   PubMedGoogle Scholar
• Ellis D. (2002). Amphotericin B: spectrum and resistance. J Antimicrob Chemother 49, Suppl A 7–10.
   PubMed Web of Science ®Google Scholar
• Elving G J, van der Mei H C, Busscher H J, van Weissenbruch R, Albers F W. (2002). Comparison of the microbial composition of voice prosthesis biofilms from patients requiring frequent versus infrequent replacement. Ann Otol Rhinol Laryngol 111, 200–203.
   PubMed Web of Science ®Google Scholar
• Elving G J, van der M H, Busscher H, van Weissenbruch R, Albers F. (2003). Influence of different combinations of bacteria and yeasts in voice prosthesis biofilms on air flow resistance. Antonie Van Leeuwenhoek 83, 45–55.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. (1998). In vitro activity of the new triazole voriconazole (UK-109496). against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 36, 198–202.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Canton E, Peman J, Rinaldi M G, Fothergill A W. (2009). Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document). in three laboratories: results obtained with 2162 clinical isolates of Candida spp and other yeasts. J Clin Microbiol 47, 2766–2771.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Quart A, Steele-Moore L, Metcheva I, Buck G A, Bruzzese V L, Reich D. (1996). Molecular karyotyping of multiple yeast species isolated from nine patients with AIDS during prolonged fluconazole therapy. J Med Vet Mycol 34, 111–116.
   PubMedGoogle Scholar
• Espinel-Ingroff A, Vazquez. J A, Boikov D, Pfaller M A. (1999). Evaluation of DNA-based typing procedures for strain categorization of Candida spp. Diagn Microbiol Infect Dis 33, 231–239.
   PubMedGoogle Scholar
• Feman S S, Nichols. J C, Chung S M, Theobald T A. (2002). Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 100, 67–70.
   PubMedGoogle Scholar
• Fenn J P, Segal H, Barland B, Denton D, Whisenant J, Chun H, Christofferson K, Hamilton L, Carroll K. (1994). Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J Clin Microbiol 32, 1184–1187.
   PubMed Web of Science ®Google Scholar
• Fisher J F, Newman C L, Sobel. J D. (1995). Yeast in the urine: solutions for a budding problem. Clin Infect Dis 20, 183–189.
   PubMedGoogle Scholar
• Fitzpatrick D A, Logue M E, Stajich. J E, Butler G. (2006). A fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis. BMC Evol Biol 6, 99.
   PubMed Web of Science ®Google Scholar
• Fleck R, Dietz A, Hof H. (2007). In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother 59, 767–771.
   PubMed Web of Science ®Google Scholar
• Flynn P M, Marina N M, Rivera G K, Hughes W T. (1993). Candida tropicalis infections in children with leukemia. Leuk Lymphoma 10, 369–376.
   PubMed Web of Science ®Google Scholar
• Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N. (2004). Candida species genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002. J Med Assoc Thai 87, 92–99.
   PubMedGoogle Scholar
• Fraser V J, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan W C. (1992). Candidemia in a tertiary care hospital: epidemiology risk factors and predictors of mortality. Clin Infect Dis 15, 414–421.
   PubMed Web of Science ®Google Scholar
• Freydiere A M, Buchaille L, Gille Y. (1997). Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens Eur. J Clin Microbiol Infect Dis 16, 464–467.
   PubMedGoogle Scholar
• Fridkin S K, Kaufman D, Edwards. J R, Shetty S, Horan T. (2006). Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 117, 1680–1687.
   PubMed Web of Science ®Google Scholar
• Fromtling R A, Abruzzo G K, Giltinan D M, 1987 Candida tropicalis infection in normal diabetic and neutropenic mice. J Clin Microbiol 25, 1416–1420.
   PubMedGoogle Scholar
• Goldani L Z, Mario P S. (2003). Candida tropicalis Fungemia in a Tertiary Care Hospital. J Infect 46, 155–160.
   PubMedGoogle Scholar
• Gottfredsson M, Vredenburgh. J J, Xu J, Schell W A, Perfect. J R. (2003). Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation. Cancer 98, 24–30.
   PubMedGoogle Scholar
• Gronemeyer P S, Weissfeld A S, Sonnenwirth A C, 1982 Purulent pericarditis complicating systemic infection with Candida tropicalis. Am J Clin Pathol 77, 471–475.
   PubMedGoogle Scholar
• Guo S, Bhattacharjee. J K. (2006). Novel lysine biosynthetic gene sequences (LYS1 and LYS5). used as PCR targets for the detection of the pathogenic Candida yeast. Appl Microbiol Biotechnol 72, 416–420.
   PubMedGoogle Scholar
• Gupta N, Haque A, Lattif A A, Narayan R P, Mukhopadhyay G, Prasad R. (2004). Epidemiology and molecular typing of Candida isolates from burn patients. Mycopathologia 158, 397–405.
   PubMedGoogle Scholar
• Hasenclever H F, Mitchell W O, 1961 Pathogenicity of C albicans and C tropicalis. Sabouraudia 1, 16–21.
   PubMedGoogle Scholar
• Heelan. J S, Sotomayor E, Coon K, D’Arezzo. J B. (1998). Comparison of the rapid yeast plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species. J Clin Microbiol 36, 1443–1445.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning D W, Patterson T F, Bennett. J E, Greene R E, Oestmann. J W, Kern W V, Marr K A, Ribaud P, Lortholary O, Sylvester R, Rubin R H, Wingard. J R, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar P H, Hodges M R, Schlamm H T, Troke P F, de Pauw B. (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347, 408–415.
   PubMed Web of Science ®Google Scholar
• Holland J, Young M L, Lee O, Chen A. (2003). Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect 79, 249–250.
   PubMed Web of Science ®Google Scholar
• Horowitz B J, Edelstein S W, Lippman L, 1985 Candida tropicalis vulvovaginitis. Obstet Gynecol 66, 229–232.
   PubMedGoogle Scholar
• Hospenthal D R, Beckius M L, Floyd K L, Horvath L L, Murray C K. (2006). Presumptive identification of Candida species other than C albicans C krusei and C tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob 5, 1.
   PubMedGoogle Scholar
• Hoyer L L, Fundyga R, Hecht. J E, Kapteyn. J C, Klis F M, Arnold J. (2001). Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family. Genetics 157, 1555–1567.
   PubMed Web of Science ®Google Scholar
• Hube B, Ruchel R, Monod M, Sanglard D, Odds F C. (1998). Functional aspects of secreted Candida proteinases. Adv Exp Med Biol 436339-44 -44.
   Google Scholar
• Huttova M, Hartmanova I, Kralinsky K, Filka J, Uher J, Kurak J, Krizan S, Krcmery V. (1998). Candida fungemia in neonates treated with fluconazole: report of forty cases including eight with meningitis. Pediatr Infect Dis J 17, 1012–1015.
   PubMed Web of Science ®Google Scholar
• Jang S J, Han H L, Lee S H, Ryu S Y, Chaulagain B P, Moon Y L, Kim D H, Jeong O Y, Shin. J H, Moon D S, Park Y J. (2005). PFGE-based epidemiological study of an outbreak of Candida tropicalis candiduria: the importance of medical waste as a reservoir of nosocomial infection. Jpn J Infect Dis 58, 263–267.
   PubMedGoogle Scholar
• Jautova J, Viragova S, Ondrasovic M, Holoda E. (2001). Incidence of Candida species isolated from human skin and nails: a survey. Folia Microbiol (Praha). 46, 333–337.
   PubMed Web of Science ®Google Scholar
• Johnson E M, Davey K G, Szekely A, Warnock D W. (1995). Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. J Antimicrob Chemother 36, 787–793.
   PubMedGoogle Scholar
• Kam A P, Xu J. (2002). Diversity of commensal yeasts within and among healthy hosts. Diagn Microbiol Infect Dis 43, 19–28.
   PubMed Web of Science ®Google Scholar
• Kleinegger C L, Lockhart S R, Vargas K, Soll D R. (1996). Frequency intensity species and strains of oral Candida vary as a function of host age. J Clin Microbiol 34, 2246–2254.
   PubMed Web of Science ®Google Scholar
• Klotz S A, Smith R L. (1992). Glycosaminoglycans inhibit Candida albicans adherence to extracellular matrix proteins. FEMS Microbiol Lett 78, 205–208.
   PubMedGoogle Scholar
• Kontoyiannis D P, Vaziri I, Hanna H A, Boktour M, Thornby J, Hachem R, Bodey G P, Raad I I. (2001). Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33, 1676–1681.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Mrazova M, Kunova A, Grey E, Mardiak J, Jurga L, Sabo A, Sufliarsky J, Sevcikova L, Sorkovska D, West D, Trupl J, Novotny J, Mateicka F. (1999). Nosocomial candidaemias due to species other than Candida albicans in cancer patients Aetiology risk factors and outcome of 45 episodes within 10 years in a single cancer institution. Support Care Cancer 7, 428–431.
   PubMed Web of Science ®Google Scholar
• Kullberg B J, Sobel. J D, Ruhnke M, Pappas P G, Viscoli C, Rex. J H, Cleary. J D, Rubinstein E, Church L W, Brown. J M, Schlamm H T, Oborska I T, Hilton F, Hodges M R. (2005). Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet 366, 1435–1442.
   PubMed Web of Science ®Google Scholar
• Kuse E R, Chetchotisakd P, da Cunha C A, Ruhnke M, Barrios C, Raghunadharao D, Sekhon. J S, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann A J, Ostrosky-Zeichner L, Lortholary O, Koblinger S, ekmann-Berndt H, Cornely O A. (2007). Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 369, 1519–1527.
   PubMed Web of Science ®Google Scholar
• Kwok Y K, Tay Y K, Goh C L, Kamarudin A, Koh M T, Seow C S. (1998). Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore. Int J Dermatol 37, 145–149.
   PubMedGoogle Scholar
• Laverdiere M, Hoban D, Restieri C, Habel F. (2002). In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. J Antimicrob Chemother 50, 119–123.
   PubMed Web of Science ®Google Scholar
• Law D, Moore C B, Wardle H M, Ganguli L A, Keaney M G, Denning D W. (1994). High prevalence of antifungal resistance in Candida spp from patients with AIDS. J Antimicrob Chemother 34, 659–668.
   PubMed Web of Science ®Google Scholar
• Lecciones J A, Lee. J W, Navarro E E, Witebsky F G, Marshall D, Steinberg S M, Pizzo P A, Walsh T J. (1992). Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 14, 875–883.
   PubMed Web of Science ®Google Scholar
• Leroy O, Gangneux. J P, Montravers P, Mira. J P, Gouin F, Sollet. J P, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O. (2009). Epidemiology management and risk factors for death of invasive Candida infections in critical care: a multicenter prospective observational study in France (2005-2006). Crit Care Med 37, 1612–1618.
   PubMed Web of Science ®Google Scholar
• Leung A Y, Chim C S, Ho P L, Cheng V C, Yuen K Y, Lie A K, Au W Y, Liang R, Kwong Y L. (2002). Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect 50, 316–319.
   PubMedGoogle Scholar
• Leung W K, Dassanayake R S, Yau. J Y, Jin L J, Yam W C, Samaranayake L P. (2000). Oral colonization phenotypic and genotypic profiles of Candida species in irradiated dentate xerostomic nasopharyngeal carcinoma survivors. J Clin Microbiol 38, 2219–2226.
   PubMed Web of Science ®Google Scholar
• Lin D, Lehmann P F. (1995). Random amplified polymorphic DNA for strain delineation within Candida tropicalis. J Med Vet Mycol 33, 241–246.
   PubMedGoogle Scholar
• Lopez C, Giro L, Ramos L, Ramadan S, Bulacio L. (2005). [Comparison of different methods for species identification of genus Candida]. Rev Argent Microbiol 37, 16–21.
   PubMedGoogle Scholar
• Lundstrom T, Sobel J. (2001). Nosocomial candiduria: a review. Clin Infect Dis 32, 1602–1607.
   PubMed Web of Science ®Google Scholar
• Luque A G, Biasoli M S, Tosello M E, Binolfi A, Lupo S, Magaro H M. (2009). Oral yeast carriage in HIV-infected and non-infected populations in Rosario Argentina. Mycoses 52, 53–59.
   PubMed Web of Science ®Google Scholar
• MacDonald L, Baker C, Chenoweth C. (1998). Risk factors for candidemia in a children’s hospital. Clin Infect Dis 26, 642–645.
   PubMed Web of Science ®Google Scholar
• MacFie J, O’Boyle C, Mitchell C J, Buckley P M, Johnstone D, Sudworth P. (1999). Gut origin of sepsis: a prospective study investigating associations between bacterial translocation gastric microflora and septic morbidity. Gut 45, 223–228.
   PubMed Web of Science ®Google Scholar
• Majithiya J, Sharp A, Parmar A, Denning D W, Warn P A. (2009). Efficacy of isavuconazole voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. J Antimicrob Chemother 63, 161–166.
   PubMed Web of Science ®Google Scholar
• Marshall. J C, Christou N V, Meakins. J L. (1993). The gastrointestinal tract The “undrained abscess” of multiple organ failure. Ann Surg 218, 111–119.
   PubMed Web of Science ®Google Scholar
• Martin M V, Wilkinson G R, 1983 The oral yeast flora of 10-year-old schoolchildren. Sabouraudia 21, 129–135.
   PubMedGoogle Scholar
• Masood A, Sallah S. (2005). Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment 1. Leuk Res 29, 493–501.
   PubMed Web of Science ®Google Scholar
• McCullers J A, Flynn P M. (1998). Candida tropicalis osteomyelitis: case report and review. Clin Infect Dis 26, 1000–1001.
   PubMed Web of Science ®Google Scholar
• McCullers J A, Vargas S L, Flynn P M, Razzouk B I, Shenep. J L. (2000). Candidal meningitis in children with cancer. Clin Infect Dis 31, 451–457.
   PubMed Web of Science ®Google Scholar
• Melo A S, Colombo A L, rthington-Skaggs B A. (2007). Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 51, 3081–3088.
   PubMed Web of Science ®Google Scholar
• Mikamo H, Sato Y, Tamaya T. (2000). In vitro antifungal activity of FK463 a new water-soluble echinocandin-like lipopeptide. J. Antimicrob Chemother 46, 485–487.
   PubMed Web of Science ®Google Scholar
• Miller D J, Mejicano G C. (2001). Vertebral osteomyelitis due to Candida species: case report and literature review. Clin Infect Dis 33, 523–530.
   PubMed Web of Science ®Google Scholar
• Nagaraja P A, Mathew T, Shetty D P. (2005). Candida tropicalis causing Prosthetic Valve Endocarditis Indian. J Med Microbiol 23, 139–140.
   Google Scholar
• Nguyen M H, Yu C Y. (1998). Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole. J Antimicrob Chemother 42, 253–256.
   PubMed Web of Science ®Google Scholar
• Nieminen M T, Uittamo J, Salaspuro M, Rautemaa R. (2009). Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol Epub 2009 Sep 29.
   PubMedGoogle Scholar
• Nucci M, Colombo A L. (2007). Candidemia due to Candida tropicalis: clinical epidemiologic and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 58, 77–82.
   PubMed Web of Science ®Google Scholar
• Odds F C, Bernaerts R. (1994). CHROMagar Candida a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32, 1923–1929.
   PubMed Web of Science ®Google Scholar
• Oksuz S, Sahin I, Yildirim M, Gulcan A, Yavuz T, Kaya D, Koc A N. (2007). Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis 60, 280–283.
   PubMed Web of Science ®Google Scholar
• Ozcan K, Ilkit M, Ates A, Turac-Bicer A, Demirhindi H. (2009). Performance of Chromogenic Candida Agar and CHROMagar Candida in recovery and presumptive identification of monofungal and polyfungal vaginal isolates. Med Mycol 1–6 Feb 4: [Epub ahead of print].
   PubMedGoogle Scholar
• Pappas P G, Kauffman C A, Andes D Benjamin D K Jr Calandra T F, Edwards J E Jr, Filler S G, Fisher. J F, Kullberg B J, Ostrosky-Zeichner L, Reboli A C, Rex. J H, Walsh T J, Sobel. J D 2009 Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48, 503–35.
   PubMed Web of Science ®Google Scholar
• Pappas P G, Rex. J H, Sobel. J D, Filler S G, Dismukes W E, Walsh T J, Edwards. J E. (2004). Guidelines for treatment of candidiasis. Clin Infect Dis 38, 161–189.
   PubMed Web of Science ®Google Scholar
• Parazzini F, Di-Cintio E, Chiantera V, Guaschino S. (2000). Determinants of different Candida species infections of the genital tract in women Sporachrom Study Geoup. Eur J Obstet Gynecol Reprod Biol 93, 141–145.
   PubMed Web of Science ®Google Scholar
• Parke D W, Jones D B, Gentry L O, 1982 Endogenous endophthalmitis among patients with candidemia. Ophthalmology 89, 789–796.
   PubMed Web of Science ®Google Scholar
• Parra-Ortega B, Cruz-Torres H, Villa-Tanaca L, Hernandez-Rodriguez C. (2009). Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species. Mem Inst Oswaldo Cruz 104, 505–512.
   PubMed Web of Science ®Google Scholar
• Pasquale T, Tomada. J R, Ghannoun M, Dipersio J, Bonilla H. (2008). Emergence of Candida tropicalis resistant to caspofungin. J Antimicrob Chemother 61, 219.
   PubMed Web of Science ®Google Scholar
• Paul N, Mathai E, Abraham O C, Mathai D. (2004). Emerging microbiological trends in Candiduria. Clin Infect Dis 39, 1743–1744.
   PubMed Web of Science ®Google Scholar
• Pfaller M A. (1996). Nosocomial candidiasis: emerging species reservoirs and modes of transmission. Clin Infect Dis 22 Suppl, 2 S89–S94.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Diekema D J, 2007a Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20, 133–163.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Diekema D J, Gibbs D L, Newell V A, Meis. J F, Gould I M, Fu W, Colombo A L, Rodriguez-Noriega E, 2007b Results from the ARTEMIS DISK Global Antifungal Surveillance Study 1997-2005: An 8 5-Year Analysis of Susceptibilities of Candida and Other Yeast Species to Fluconazole and Voriconazole by CLSI Standardized Disk Diffusion Testing. J Clin Microbiol 45,1735–45.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Diekema D J, Jones R N, Sader H S, Fluit A C, Hollis Messer S A. (2001). International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 39, 3254–3259.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Diekema D J, Messer S A, Hollis R J, Jones R N. (2003). In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3959 Clinical Isolates of Candida spp, Including 157 Fluconazole-Resistant Isolates. Antimicrob Agents Chemother 47, 1068–1071.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Diekema D J, Sheehan D J. (2006). Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 19, 435–447.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Jones R N, Doern G V, Fluit A C, Verhoef J, Sader H S, Messer S A, Houston A, Coffman S, Hollis R J. (1999). International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis 35, 19–25.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Jones R N, Doern G V, Sader H S, Messer S A, Houston A, Coffman S, Hollis R J. (2000). Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America 1997-1998. Antimicrob Agents Chemother 44, 747–751.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Messer S, Jones R N. (1997). Activity of a new triazole Sch 56592 compared with those of four other antifungal agents tested against clinical isolates of Candida spp and Saccharomyces cerevisiae. Antimicrob Agents Chemother 41, 233–235.
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Rhine-Chalberg J, Redding S W, Smith J, Farinacci G, Fothergill A W, Rinaldi M G. (1994). Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 32, 59–64.
   PubMed Web of Science ®Google Scholar
• Presterl E, Daxbock F, Graninger W, Willinger B. (2007). Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna Austria. Clin Microbiol Infect 13, 1072–1076.
   PubMedGoogle Scholar
• Rangel-Frausto M S, Houston A K, Bale M J, Fu C, Wenzel R P. (1994). An experimental model for study of Candida survival and transmission in human volunteers Eur. J Clin Microbiol Infect Dis 13, 590–595.
   PubMedGoogle Scholar
• Redding S P, Rinaldi M G, Hicks. J L, 1988 The relationship of oral Candida tropicalis infection to systemic candidiasis in a patient with leukemia Spec Care Dentist 8, 111–114.
   PubMedGoogle Scholar
• Revankar S G, Kirkpatrick W R, McAtee R K, Fothergill A W, Redding S W, Rinaldi M G, Patterson T F. (1998). Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method. J Clin Microbiol 36, 153–156.
   PubMed Web of Science ®Google Scholar
• Rex J H. (1996). Editorial response: catheters and candidemia. Clin Infect Dis 22, 467–470.
   PubMed Web of Science ®Google Scholar
• Rex J H, Cooper C R, Merz W G, Galgiani. J N, Anaissie E J, 1995a Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother 39, 906–909.
   PubMed Web of Science ®Google Scholar
• Rex. J H, Rinaldi M G, Pfaller M A, 1995b Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39, 1–8.
   PubMed Web of Science ®Google Scholar
• Richter S S, Galask R P, Messer S A, Hollis R J, Diekema D J, Pfaller M A. (2005). Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 43, 2155–2162.
   PubMed Web of Science ®Google Scholar
• Rivett A G, Perry. J A, Cohen J, 1986 Urinary candidiasis: a prospective study in hospital patients. Urol Res 14, 183–186.
   PubMedGoogle Scholar
• Rodriguez-Adrian L J, King R T, Tamayo-Derat L G, Miller. J W, Garcia C A, Rex. J H. (2003). Retinal lesions as clues to disseminated bacterial and candidal infections: frequency natural history and etiology. Medicine (Baltimore) 82, 187–202.
   PubMed Web of Science ®Google Scholar
• Roilides E, Farmaki E, Evdoridou J, Dotis J, Hatziioannidis E, Tsivitanidou M, Bibashi E, Filioti I, Sofianou D, Gil-Lamaignere C, Mueller F M, Kremenopoulos G. (2004). Neonatal candidiasis: analysis of epidemiology drug susceptibility and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 23, 745–750.
   PubMed Web of Science ®Google Scholar
• Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, Filioti J, Tsivitanidou M, Sofianou D, Kremenopoulos G, Walsh T J. (2003). Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 41, 735–741.
   PubMedGoogle Scholar
• Roling E E, Klepser M E, Wasson A, Lewis R E, Ernst E J, Pfaller M A. (2002). Antifungal activities of fluconazole caspofungin (MK0991). and anidulafungin (LY 303366). alone and in combination against Candida spp and Crytococcus neoformans via time-kill methods. Diagn Microbiol Infect Dis 43, 13–17.
   PubMed Web of Science ®Google Scholar
• Sabino R, Verissimo C, Brandao J, Alves C, Parada H, Rosado L, Paixao E, Videira Z, Tendeiro T, Sampaio P, Pais C. (2009). Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital. Med Mycol 1–10 Aug 5 [Epub ahead of print].
   PubMedGoogle Scholar
• Sallam A, Lynn W, McCluskey P, Lightman S. (2006). Endogenous Candida endophthalmitis. Expert Rev Anti Infect Ther 4, 675–685.
   PubMedGoogle Scholar
• Schaller M, Korting H C, Schafer W, Bastert J, Chen W, Hube B. (1999). Secreted aspartic proteinase (Sap). activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 34, 169–180.
   PubMed Web of Science ®Google Scholar
• Sebastiani G D, Galas F. (2001). Spondylodiscitis due to Candida tropicalis as a cause of inflammatory back pain. Clin Rheumatol 20, 435–437.
   PubMedGoogle Scholar
• Shin J H, Kee S J, Shin M G, Kim S H, Shin D H, Lee S K, Suh S P, Ryang D W. (2002). Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40, 1244–1248.
   PubMed Web of Science ®Google Scholar
• Simor A E, Goswell G, Louie L, Lee M, Louie M. (1997). Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test Eur. J Clin Microbiol Infect Dis 16, 693–697.
   PubMed Web of Science ®Google Scholar
• Singhi S, Rao D S, Chakrabarti A. (2008). Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 9, 91–95.
   PubMed Web of Science ®Google Scholar
• Sipsas N V, Lewis R E, Tarrand J, Hachem R, Rolston K V, Raad I I, Kontoyiannis D P. (2009). Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007).: stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115, 4745–4752.
   PubMed Web of Science ®Google Scholar
• Skiest D J, Vazquez. J A, Anstead G M, Graybill. J R, Reynes J, Ward D, Hare R, Boparai N, Isaacs R. (2007). Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. Clin Infect Dis 44, 607–614.
   PubMed Web of Science ®Google Scholar
• Slavin M A. (2002). The epidemiology of candidaemia and mould infections in Australia. J Antimicrob Chemother 49, Suppl 1 3–6.
   PubMed Web of Science ®Google Scholar
• Slavin M A, Szer J, Grigg A P, Roberts A W, Seymour. J F, Sasadeusz J, Thursky K, Chen S C, Morrissey C O, Heath C H, Sorrell A T. (2004). Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections. Intern Med J 34, 192–200.
   PubMed Web of Science ®Google Scholar
• Sobel. J D. (2006). The Emergence of Non-albicans Candida Species as Causes of Invasive Candidiasis and Candidemia. Curr Infect Dis Rep 8, 427–433.
   PubMedGoogle Scholar
• Sobel. J D, Kauffman C A, McKinsey D, Zervos M, Vazquez. J A, Karchmer A W, Lee J, Thomas C, Panzer H, Dismukes W E. (2000). Candiduria: a randomized double-blind study of treatment with fluconazole and placebo The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 30, 19–24.
   PubMed Web of Science ®Google Scholar
• Staib P, Wirsching S, Strauss A, Morschhauser J. (2001). Gene regulation and host adaptation mechanisms in Candida albicans. Int J Med Microbiol 291, 183–188.
   PubMedGoogle Scholar
• Stapleton A. (2002). Urinary tract infections in patients with diabetes. Am J Med 113 Suppl 1A, 80S–84S.
   Google Scholar
• Steffan P, Vazquez. J A, Boikov D, Xu C, Sobel. J D, Akins R A. (1997). Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates. J Clin Microbiol 35, 2031–2039.
   PubMed Web of Science ®Google Scholar
• Stovall W D, Pessin S B 1933 Classification and pathogenicity of certain monilias. Am J Clin Pathol 3, 347–365.
   Google Scholar
• Suzuki T, Miyamae Y, Ishida I. (1991). Variation of colony morphology and chromosomal rearrangement in Candida tropicalis pK233. J Gen Microbiol 137, 7.
   Google Scholar
• Tan T Y, Tan A L, Tee N W, Ng L S, Chee C W. (2009). The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. Mycoses Jul 10 [Epub ahead of print].
   Google Scholar
• Thaweboon S, Thaweboon B, Srithavaj T, Choonharuangdej S. (2008). Oral colonization of Candida species in patients receiving radiotherapy in the head and neck area. Quintessence Int 39, e52–e57.
   PubMedGoogle Scholar
• Torres H A, Hachem R Y, Chemaly R F, Kontoyiannis D P, Raad I I. (2005). Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5, 775–785.
   PubMed Web of Science ®Google Scholar
• Tortorano A, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A. (2002). European Confederation of Medical Mycology (ECMM). prospective survey of candidaemia: report from one Italian region. J Hosp Infect 51, 297.
   PubMed Web of Science ®Google Scholar
• Tortorano A M, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. (2006). Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27, 359–366.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Caldarola G, Tacconelli E, Morace G, Posteraro B, Cauda R, Ortona L. (1996). Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. J Antimicrob Chemother 38. 691–699.
   Google Scholar
• Tumbarello M, Posteraro B, Trecarichi E M, Fiori B, Rossi M, Porta R, de Gaetano D K, La S M, Spanu T, Fadda G, Cauda R, Sanguinetti M. (2007). Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45, 1843–1850.
   PubMed Web of Science ®Google Scholar
• Vanden A A, de M H, Ahariz M, Perraudin. J P, Beyer I, Courtois P. (2008). Denture contamination by yeasts in the elderly. Gerodontology 4, 222–8.
   Google Scholar
• Vandeputte P, Larcher G, Berges T, Renier G, Chabasse D, Bouchara. J P. (2005). Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother 49. 4608–4615.
   Google Scholar
• Vigouroux S, Morin O, Moreau P, Harousseau. J L, Milpied N. (2006). Candidemia in patients with hematologic malignancies: analysis of 7 years’ experience in a single center. Haematologica 91, 717–718.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebeau B, Spence D, Krcmery V, De-Pauw B, Meunier F. (1999). Candidemia in cancer patients: a prospective multicenter surveillance study by the Invasive Fungal Infection Group (IFIG). of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28, 1071–1079.
   PubMed Web of Science ®Google Scholar
• Vogel C, Rogerson A, Schatz S, Laubach H, Tallman A, Fell J. (2007). Prevalence of yeasts in beach sand at three bathing beaches in South Florida. Water Res 41, 1915–1920.
   PubMed Web of Science ®Google Scholar
• Wang J L, Chang S C, Hsueh P R, Chen Y C. (2004). Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002. J Microbiol Immunol Infect 37, 236–241.
   PubMedGoogle Scholar
• Warn P A, Morrissey J, Moore C B, Denning D W. (2000). In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Antimicrob Agents Chemother 44, 2664–2671.
   PubMedGoogle Scholar
• Warn P A, Sharp A, Morrissey G, Denning D W. (2002). In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis. J. Antimicrob Chemother 50, 1071–1074.
   PubMed Web of Science ®Google Scholar
• Warn P A, Sharp A, Morrissey G, Denning D W. (2005). Activity of aminocandin (IP960). compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis. J Antimicrob Chemother 56, 590–593.
   PubMed Web of Science ®Google Scholar
• Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, Bash E, Turner D, Goldschmied-Reouven A, Regev-Yochay G, Pitlik S D, Keller N. (2005). Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 61, 146–154.
   PubMedGoogle Scholar
• Wingard J R. (1995). Importance of Candida species other than C albicans as pathogens in oncology patients. Clin Infect Dis 20, 115–125.
   PubMed Web of Science ®Google Scholar
• Wise G J. (2001). Genitourinary fungal infections: a therapeutic conundrum. Expert Opin Pharmacother 2, 1211–1226.
   PubMedGoogle Scholar
• Wisplinghoff H, Bischoff T, Tallent S M, Seifert H, Wenzel R P, Edmond M B. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309–317.
   PubMed Web of Science ®Google Scholar
• Wolfson. J S, Sober A J, Rubin R H, 1985 Dermatologic manifestations of infections in immunocompromised patients. Medicine (Baltimore ) 64, 115–133.
   PubMed Web of Science ®Google Scholar
• Yang C W, Barkham T M, Chan F Y, Wang Y. (2003). Prevalence of Candida Species Including Candida dubliniensis in Singapore. J Clin Microbiol 41, 472–474.
   PubMedGoogle Scholar
• Yang Y L, Cheng M F, Wang C W, Wang A H, Cheng W T, Lo H J. (2009). The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med Mycol 1-7.
   Google Scholar
• Yang Y L, Wang A H, Wang C W, Cheng W T, Li S Y, Lo H J. (2008). Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn Microbiol Infect Dis 61, 175–180.
   PubMedGoogle Scholar
• Yap H Y, Kwok K M, Gomersall C D, Fung S C, Lam T C, Leung P N, Hui M, Joynt G M. (2009). Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong. Hong Kong Med J 15, 255–261.
   PubMedGoogle Scholar
• Yucesoy M, Ozbek O A, Marol S. (2005). Comparison of three differential media for the presumptive identification of yeasts. Clin Microbiol Infect 11, 245–247.
   PubMedGoogle Scholar
• Zaas A K, Dodds Ashley E S, Alexander B D, Johnson M D, Perfect. J R. (2006). Caspofungin for invasive candidiasis at a tertiary care medical center. Am J Med 119, 993–996.
   PubMedGoogle Scholar
• Zaugg C, Borg-von-Zepelin M, Reichard U, Sanglard D, Monod M. (2001). Secreted aspartic proteinase family of Candida tropicalis. Infect Immun 69, 405–412.
   PubMed Web of Science ®Google Scholar
• Zedtwitz-Liebenstein K, Gabriel H, Willinger B, Ehringer H, Polterauer P, Graninger W. (2001). Prosthetic valve endocarditis due to Candida tropicalis complicated by multiple pseudoaneurysms. Infection 29, 177–179.
   PubMed Web of Science ®Google Scholar